PCRX Pacira Pharmaceuticals Future Profit

Official company branding of Pacira Pharmaceuticals (PCRX)

Pacira BioSciences management effectively protects patents while expanding the non-opioid analgesic segment. High scientific potential enables the development of innovative liposomal drug delivery methods. Optimized routes and specialized hubs guarantee supply stability. This revenue forecast chart contrasts speculative demand with the fundamental valuation of the business, with the indicator value standing at 0.14.

pacira.com (PCRX): Expected Net Profit from 07/04/2022 to 11/15/2026

Pacira - analytical breakdowns and key metrics (PCRX)

- share price and consensus valuation forecast:
Fundamental company analysis:PCRX, Pacira BioSciences, Inc.
Finished products of Pacira Pharmaceuticals

To identify fundamental benchmarks, investors require a tool that promptly aggregates analysts' net income revisions, bypassing quarterly delays. This forward-looking financial metric captures business valuation trends, reflecting through estimated expectations the success of the Pacira BioSciences (PCRX) expansion strategy within the non-opioid analgesic segment and the effectiveness of management's patent portfolio protection.

Competitor analysis for Pacira BioSciences

Future Profit HLN|Projected Future Earnings Kenvue Corp|Future Profit VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Expected Net Income|Expected Profit Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Expected Net Profit|PRGO: Future Profit|Alvotech SA - Future Net Profit|LQDA: Projected Future Earnings|Galapagos Genomics - Expected Net Income|ANIP (ANI Pharmaceuticals Inc) - Projected Future Earnings|Expected Net Profit mannkindcorp.com MNKD|Expected Profit Amphastar Pharmaceuticals, Inc. (AMPH)|SPRY (ARS Pharmaceuticals, Inc.) - Expected Net Income|Theravance Biopharma, Inc. - Future Profit|Projected Future Earnings Aquestive Corp AQST|scPharmaceuticals - Projected Future Earnings|Expected Net Profit tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Expected Profit|SXTC - Company Profit Forecast|Expected Profit eupraxiapharma.com|BHST: Expected Net Income|Future Profit EXOZ (Invizyne Technologies)|ORMP - Expected Net Profit|Projected Future Earnings ENTX (Entera Bio Ltd)|Projected Future Earnings MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Projected Future Earnings|CPIX: Expected Profit|QNTM (Quantum BioPharma Ltd) - Future Profit|Net Profit Forecast FGEN|Expected Profit Telomir Pharmaceuticals|RANI: Expected Net Income|Projected Future Earnings SNYR|Future Profit Rallybio Corp RLYB|Expected Profit Lexaria Bioscience Corp. LEXX|Company Profit Forecast pulmatrix.com (PULM)|Pheton Holdings Limited - Projected Future Earnings|Forward Earnings APM|LYRA (Lyra Therapeutics Inc.) - Future Profit|IBO - Company Profit Forecast|Future Profit TNFA|Net Profit Forecast YCBD (cbdmd.com)|Future Profit PRFX (PainReform Ltd)|CYTO: Forward Earnings|Projected Future Earnings LIPO (lipella.com)|Future Net Profit OPTN (OptiNose Corp)|PIRS: Future Profit|PROC - Projected Future Earnings|PTPI: Projected Future Earnings|Qilian International Holding Group (QLI) - Projected Future Earnings|SLRN (ACELYRIN, Inc.) - Projected Future Earnings|TFF Pharmaceuticals (TFFP) - Company Profit Forecast